- Home
- KE vs MAZE Comparison
KE vs MAZE Comparison
Compare KE & MAZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KE
- MAZE
- Stock Information
- Founded
- KE 1961
- MAZE 2018
- Country
- KE United States
- MAZE United States
- Employees
- KE N/A
- MAZE N/A
- Industry
- KE Electrical Products
- MAZE
- Sector
- KE Technology
- MAZE
- Exchange
- KE Nasdaq
- MAZE NYSE
- Market Cap
- KE 442.5M
- MAZE 523.1M
- IPO Year
- KE N/A
- MAZE 2025
- Fundamental
- Price
- KE $16.01
- MAZE $10.37
- Analyst Decision
- KE Buy
- MAZE Strong Buy
- Analyst Count
- KE 5
- MAZE 3
- Target Price
- KE $22.20
- MAZE $25.67
- AVG Volume (30 Days)
- KE 127.9K
- MAZE 318.8K
- Earning Date
- KE 05-06-2025
- MAZE 01-01-0001
- Dividend Yield
- KE N/A
- MAZE N/A
- EPS Growth
- KE N/A
- MAZE N/A
- EPS
- KE 0.32
- MAZE 1.25
- Revenue
- KE $1,586,842,000.00
- MAZE $167,500,000.00
- Revenue This Year
- KE N/A
- MAZE N/A
- Revenue Next Year
- KE N/A
- MAZE N/A
- P/E Ratio
- KE $50.69
- MAZE $8.28
- Revenue Growth
- KE N/A
- MAZE N/A
- 52 Week Low
- KE $15.81
- MAZE $9.50
- 52 Week High
- KE $24.45
- MAZE $17.00
- Technical
- Relative Strength Index (RSI)
- KE 34.38
- MAZE N/A
- Support Level
- KE $16.00
- MAZE N/A
- Resistance Level
- KE $17.18
- MAZE N/A
- Average True Range (ATR)
- KE 0.46
- MAZE 0.00
- MACD
- KE -0.06
- MAZE 0.00
- Stochastic Oscillator
- KE 12.17
- MAZE 0.00
About KE Kimball Electronics Inc.
Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.
About MAZE MAZE THERAPEUTICS INC
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.